Australian Confidence In Biosimilar Switching ‘More Than Doubled Since 2016’

Over 650 Healthcare Professionals And Consumers Surveyed In New Report

A new reported commissioned by Australia’s Generic and Biosimilar Medicines Association shows a ‘marked increase’ in confidence for biosimilars among a number of different stakeholders.

Magnifying glass focusing on Australia
The GBMA emphasized the benefits of continuing professional development accredited education • Source: Shutterstock

More from Biosimilars

More from Products